Carmignac Gestion

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1569758 PARIS, I0

Position in ESPR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$0

New position

Shares Held

1,659,399

first reported quarter

Ownership

0.645%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Carmignac Gestion holds $297,984,910 across 4 Drug Manufacturers - Specialty & Generic names. ESPR ranks #4 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc.	1,340,100	$148,670,694
2	ZTS	Zoetis Inc.	1,575,700	$113,229,802
3	NBIX	Neurocrine Biosciences Inc	214,100	$36,084,414
4	ESPR	Esperion Therapeutics, Inc. This page	1,659,399	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	1,659,399	—	Shares	Sole	2026-08-13
No filing history on record for this holder in this stock.